Horizon Therapeutics Q3 EPS $0.64 Beats $0.49 Estimate, Sales $335.466M Beat $329.76M Estimate

Horizon Therapeutics (NASDAQ:HZNP) reported quarterly earnings of $0.64 per share which beat the analyst consensus estimate of $0.49 by 30.61 percent. This is a 1.54 percent decrease over earnings of $0.65 per share from

Benzinga · 11/06/2019 13:12

Horizon Therapeutics (NASDAQ:HZNP) reported quarterly earnings of $0.64 per share which beat the analyst consensus estimate of $0.49 by 30.61 percent. This is a 1.54 percent decrease over earnings of $0.65 per share from the same period last year. The company reported quarterly sales of $335.466 million which beat the analyst consensus estimate of $329.76 million by 1.73 percent. This is a 3.12 percent increase over sales of $325.311 million the same period last year.